Patent · US Expired

Expression monitoring of downstream genes in the BRCA1 pathway

US6258536A · kind A · utility

15Cited by
5References
32Claims
0Family size

Inventors

Key dates

Filing dateDec 1, 1998
Grant dateJul 10, 2001
Priority date
Expiry dateDec 1, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q1/6809
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Analysis of the genes whose expression is affected by BRCA1 has identified a set of genes, each of which is up- or down-regulated by BRCA1. Each of these genes, alone or in groups, can be used to determine the mutational status of a BRCA1 gene, to determine whether a particular allelic variant affects BRCA1 function, to diagnose neoplasia, and to help identify candidate drugs which may be useful as anti-neoplastic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.